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Abstract.  Using a novel in vitro assay which allows 
us to distinguish vesicle budding from subsequent tar- 
geting and fusion steps, we provide the first biological 
evidence that B-COP, a component of non-clathrin- 
coated vesicles believed to mediate intraGolgi trans- 
port,  is essential for transport of protein from the ER 
to the cis-Golgi compartment.  Incubation in the pres- 
ence of B-COP specific antibodies and Fab fragments 
prevents the exit of vesicular stomatitis virus glycopro- 
tein (VSV-G)  from the ER. These results demonstrate 
that fl-COP is required for the assembly of coat com- 
plexes mediating vesicle budding.  Fractionation of 
rat liver cytosol revealed that a major biologically ac- 
tive form of B-COP was found in a high molecular 
pool (>1,000 kD) distinct from coatomer and which 
promoted efficient vesicle budding from the ER.  Sur- 
prisingly,  rablB could be quantitatively coprecipitated 
with this/3-COP containing  complex and was also es- 
sential for function.  We suggest that/3-COP functions 
in an early step during vesicle formation and that 
rablB may be recruited as a component of a precoat 
complex which participates in the export of protein 
from the ER via vesicular carders. 
LUCIDATION of the  molecular  mechanisms  which 
regulate  the  formation  of carrier  vesicles  which 
transport protein from the ER through sequential cis-, 
medial-, and trans-Golgi compartments is central  to under- 
standing  the secretory pathway of eukaryotic cells (for re- 
view see Rothman  and Orci,  1992).  Proteins which play a 
key role in this process are those that serve as soluble coat 
precursors  for  vesicle  budding.  The  coatomer  complex 
(Waters et al.,  1991b), a protein complex (14S) which con- 
tains o~,/3, 3', and ~-COP subunits, has been proposed to be 
a component of non-clathrin  coats found on vesicles mediat- 
ing  traffic  between Golgi  compartments  (for  review  see 
Duden et al.,  1991a; Waters  et al.,  1991a). However,  its 
role(s) as a precursor remains controversial  due to lack of 
a direct demonstration of its biological role in transport (for 
review see Klausner et al.,  1992). A second set of proteins 
are those found to mediate vesicle budding in yeast (for re- 
view see Pryer et al., 1992). They include among others the 
small GTP-binding  protein SAR1 (Nakano and Muramatsu, 
1989; Barlowe et al.,  1993),  SEC23 (a SAR1 GTPase ac- 
tivating  protein  (GAP) ~ (Hicke et al.,  1992;  Yoshihisa et 
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al.,  1993), and SEC12 (a SAR1 specific guanine nucleotide 
exchange  protein  (GDS)  (Nakano  and  Schekman,  1988; 
d'Enfert et al., 1992). Sec21, the yeast homologue to 3,COP, 
is also required for a step in ER to Golgi transport, although 
its functional  role is presently unknown  (Hosobuchi et al., 
1992). While many of these proteins can be used to generate 
partial reactions leading to vesicle budding,  direct evidence 
for their role in supporting  a complete round of transport is 
currently lacking. 
We have been interested in understanding  the biochemical 
role of the small GTP-binding  protein rabl in ER to Golgi 
transport in mammalian  cells.  Rabl belongs to a family of 
proteins which are now considered to serve as GTP/GDP 
regulated  molecular switches governing the function of the 
exocytic and endocytic pathways. Biochemical  and genetic 
evidence suggests that rab proteins regulate the flow of pro- 
tein between restricted subsets of intracellular  compartments 
(for review see Goud and McCaffrey,  1991; Pfeffer, 1992). 
For example, whereas both rabl (Plutner et al., 1991; Schwa- 
ninger  et  al.,  1992;  Tisdale  et  al.,  1992;  Davidson  and 
Balch,  1993) and its yeast homologue, YPT1 (Schmitt et al., 
1988;  Segev et al.,  1988; Bacon et al.,  1989; Baker et al., 
1990;  Segev, 1991; for review see Pryer et al.,  1992).  In- 
terestingly,  SEC4 is associated with a  19.5S complex con- 
taining other proteins (SEC8 and SEC15) recognized to me- 
diate  the function  of vesicle carders en route to the cell 
surface (Bowser et al., 1992). The identity of transport com- 
ponents  regulated by rabl  or YPT1, and their role in the 
different steps of vesicle formation,  targeting,  and fusion is 
unknown. 
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components in the temporal events leading up to vesicle bud- 
ding from the ER, we have examined the role of  B-COP using 
an in vitro assay which efficiently reconstitutes this state of 
the secretory pathway in the test tube (Schwaninger et "al., 
1992; Plutner et al., 1992; Davidson and Balch, 1993). We 
provide evidence that antibodies and F~b fragments specific 
for B-COP efficiently inhibit vesicle budding from the ER. 
The principal targets for these antibodies were soluble com- 
ponents found in rat liver cytosol. Fractionation of cytosol 
using gel filtration revealed the presence of two biologically 
active pools.  A high molecular  weight B-COP containing 
complex (18-19S), which contained only 10-20% of  the total 
soluble B-COP present in cytosol, promoted efficient export 
of vesicular stomatitis virus glycoprotein (VSV-G) from the 
ER.  Intriguingly, this  complex contained  both  rablB  and 
B-COP, both of which were required for complex function. 
We suggest that B-COP and rablB may be recruited  coor- 
dinately to the ER membrane in a precursor complex during 
the  assembly  of coats  involved in  vesicle  budding  from 
the ER. 
Materials and Methods 
Materials 
Assay reagents were obtained as described previously (Plutner et al., 1992). 
Antibodies specific for rablB (m4D3c, 5C6b and p68) were prepared as pre- 
viously described (Plutner et al.,  1990).  Monoclonal and polyclonal anti- 
bodies specific for fl-COP were prepared as previously described (Duden 
et al., 1991b; Pepperkok et al., 1993).  Antibodies were kindly provided by 
the following individuals: a polyclonal antibody (R37) specific for ARF by 
R.  Kahn,  Laboratory  of Cancer Treatment,  National  Cancer Institute, 
Bethesda, MD; a polyclonal antibody to Sec23p by R. Schekman, Univer- 
sity of California, Berkeley, CA; a polyclonal antibody specific for p58 by 
J. Saraste, University of  Bergen, Department of  Biochemistry, Bergen, Nor- 
way; monoclonal antibodies to NSF by J. Rothman (Sloan Kettering Insti- 
tute, Department of Cellular Biochemistry and Biophysics, NY), and M. 
Tagaya (Osaka University, Institute of Scientific and Industrial Research, 
Osaka, Japan). Recombinant fl-COP was prepared from SF9 insect cells by 
expression from a baculovirns vector containing the coding sequence for 
fl-COP (provided by T. Kreis). Coatomer (Waters et al., 1992) was kindly 
provided by J. Rothman, Department of Cellular Biophysics and Biochemis- 
try, Sloan Kettering, NY and G. Waters, Department of Molecular Biology, 
Princeton University, Princeton, NJ. 
Incubation Conditions and Analysis of Transport 
The ER to Golgi transport assays using permeabilized NRK cells infected 
with tsO45 VSV were performed as described previously (Beckers et al., 
1987; Plutner et ai., 1992).  Briefly,  for biochemical qnantitation of trans- 
port incubations contained in a final total volume of 40/~1 (final concentra- 
tion): 25 mM Hepes-KOH (pH 7.2), 75 mM KOAc, 2.5 mM MgOAc, 5 mM 
EGTA,  1.8 mM CaCI2,  1 mM ATP, 5 mM creatine phosphate, 0.2 IU of 
rabbit muscle creatine pbosphokinase, 25-75 #g cytosol, and 5/zl (25-30 
~g of protein; 1-2 x  10  s cells) of semi-intact cells. Transport was initiated 
by transfer to 32°C. After termination of transport by transfer to ice, the 
membranes were pelleted by a brief (15 s) centrifugation in a microfuge at 
top speed. For analysis of processing of VSV-G protein to the Man5 form, 
the pellet was subsequently solubilized in an endoglycosidase D (endo D) 
digestion buffer and digested with endo D as described previously (David- 
son and Balch, 1993).  Endo D digestions were terminated by adding a 5x 
concentrated gel sample buffer (Laemmli,  1970)  and boiling for 5  min. 
Where indicated, samples were analyzed for the appearance of the en- 
doglycosidase H (endo H) resistant form as described previously (Plutner 
et al., 1992).  The fraction of VSV-G protein processed to the endo D sensi- 
tive or endo H resistant forms was quantitated by densitometry (Beckers 
and Balch,  1989)  or using an AMBIS  TM radioanalytic imaging system. 
Experimental procedures for digitouln permeabilization, incubation in 
vitro and indirect immunofluorescence were as described previously (Plut- 
ner et ai.,  1992).  In all experiments, NRK cells were permeabilized with 
40/~g/ml digitonin. 
Transport of VSV-G protein from the ER to the p58 containing punctate 
pre-Golgi intermediates was quantitated using indirect immnnofluorescence 
(Plutner et al., 1992; Schwaninger et al., 1992; Pind et al., 1993).  Briefly, 
fields of cells were randomly chosen and the number of pre-Golgi punctate 
structures containing VSV-G determined for each cell in a  given field. 
Generally, 10 fields with an average of 10 cells per field were counted with 
the total number of punctate structures ranging from none (no transport) 
to 30-60 per cell under optimal transport conditions. Pre-Golgi intermedi- 
ates are very distinct in terms of their compact structure and fluorescence 
intensity compared to the diffuse staining of VSV-G protein when present 
in the extended ER network (Plutner et al.,  1992). 
Appearance of VSV-G protein in punctate structures strongly correlates 
(>75 %) with its colocalization with the p58 marker protein or colocaliza- 
tion (>90%) with rablB containing punctate intermediates (Plutner et al., 
1992;  Schwaninger et al.,  1992).  The number of punctate structures de- 
tected in a given cell is proportional to the concentration of cytosol in the 
assay,  the time of incubation, as well as being sensitive to a broad range 
of reagents affecting VSV-G transport (Plutner et al., 1992; Schwaninger et 
al., 1992).  These structures consist of clusters of vesicles and small tubular 
elements as determined by immunoelectmn microscopy (Find et al., 1993). 
By totaling the number of pre-Golgi punctate structures containing VSV-G 
for each cell in a field for a given experimental condition, the average num- 
ber of punctate structures observed per cell over all counted fields was ob- 
tained. The statistical variation between cells was routinely within 5-15% 
of the average value reported in Results for different experiments. 
The transport of VSV-G to morphologically distinct intermediates serves 
as a semiquantitative measure of the extent of export of VSV-G from the 
diffuse ER network. Results are generally reported as % of total number 
of punctate structures observed compared to control incubations containing 
a maximal stimulatory level of rat liver cytosol or the Superose 6 void pool 
as indicated in Results. This control value was set as 100. 
Precipitation of rablB/fl-COP-containing Complexes 
Rat liver cytosol prepared as described previously (Davidson and Balch, 
1992) was centrifuged for 10 min in a microfuge (or 10 rain at 150,000  g 
in an Airfuge [Beckman Instruments, Palo Alto, CA] with identical results). 
The supernate (10-15  mg/ml) of unfractionated cytosol or the Superose 6 
void fraction (see below) was combined with the rablB specific m4D3c, or 
fl-COP specific M3AS, or Dim antibodies (in 25 mM Hepes Loll 7.2], 125 
mM KOAc [25/125l)  to yield a final concentration of 50 ng antibody per 
~g cytosoi. The antibody containing cytosol was incubated on ice overnight. 
Subsequently, the cytosol was centrifuged for 10 min in a microfuge to re- 
move pelletable material. Under the conditions used to assay transport as 
described in Results, the concentration of  antibodies remaining in the super- 
nate do not inhibit transport when added separately.  Where indicated, 
precipitates were resuspended by trituration in 25/125 and washed once by 
centrifugation for 10 rain in a microfuge. 
To determine the composition of immune complexes formed in the pres- 
ence of m4D3c or M3A5,  200 #l of the Snperose 6 pooled void fractions 
was incubated for 1 h on ice in the presence of 5/zg of the respective anti- 
body  followed  by  the  addition  of  5  mg  protein  A-Sepharose  beads 
(pretreated with 0.1% milk) for 1 h on ice. Beads were subsequently washed 
five times with 25/125  and bound proteins released using lx  gel sample 
buffer (Laemmli,  1970).  Samples were separated using SDS-PAGE and 
transferred to nitrocellulose for blotting with either p68 or M3A5 antibod- 
ies. Western blotting was performed as described previously (Tisdale et al., 
1992). 
Gel Filtration 
A Superose 6  TM column (Pharmacia LKB Biotechnology, Piscataway,  N J) 
was equilibrated with four column volumes of 25/125  buffer and 0.5 ml of 
pre-spun rat liver cytosol was fractionated at a flow rate of  0.4 ml/min. Frac- 
tions of 0.5 ml were collected and assayed immediately as described above. 
SDS-PAGE and/or Western blotting was performed as described previously 
using 1% milk as a blocking reagent (Tisdaie et al., 1992).  Protein concen- 
trations were determined using a Biorad protein kit (Biorad Labs., Rich- 
mond, VA). 
Sucrose Velocity Sedimentation 
The sedimentation value of the rablB-containing fraction present in the Su- 
perose 6  void fraction was determined exactly as described previously 
(Duden et al.,  1991b). 
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Figure 1. Antibodies specific for B-COP inhibit ER to Golgi trans- 
port in vitro. (A) Permeabilized cells, cytosol, and ATP were prein- 
cubated with the indicated antibodies specific for B-COP for 1 h 
on ice before incubation in vitro for 75 min. Transport conditions 
were as follows: (a) 75-rain incubation on ice; (b) 75-min incuba- 
tion at 32°C (no antibody); pretreatment with either M3A5 (6 #g) 
(c), 110-2 (2 #g) (d), E1 (2 #g) (e), polyclonal Dlp (2 #g) (f), or 
EAGE (6 #g) (g); (h and 0 pretreatment with monoclonal reagent 
Dim (4 #g). In lane i, the Dlm containing assay was supplemented 
Results 
Antibodies Specific for ~S-COP Inhibit Export of VSV-G 
from the ER 
To assess the functional role of/S-COP in ER to Golgi trans- 
port, we tested a number of/S-COP specific monoclonal and 
polyclonal antibodies to determine if they inhibit the deliv- 
ery of VSV-G to the Golgi stack.  Transport in vitro using 
semi-intact or permeabilized cells can be measured by the 
processing of VSV-G to the endo D sensitive form or to the 
endo H resistant R~ form upon arrival in the cis-Golgi com- 
partments (Schwaninger et al.,  1992; Plutner et al.,  1992; 
Davidson and Balch,  1993). Both assays are indistinguish- 
able in their kinetics of transport and biochemical require- 
ments  (Schwaninger  et  al.,  1992;  Plutner  et  al.,  1992; 
Davidson and Balch,  1993). 
Six different/S-COP specific antibodies inhibited VSV-G 
transport in vitro (Fig.  1 A, c-h). All but one strongly in- 
hibited transport when semi-intact cells and cytosol were 
preincubated with antibody for 1 h on ice before incubation 
in vitro. Three of  these antibodies, designated 110-2, El, and 
Dlp,  were affinity purified polyclonal antibodies prepared 
against  synthetic peptides  to  different regions  of/S-COP 
(Duden et al.,  1991b;  Pepperkok et al.,  1993).  Two were 
monoclonal reagents, one prepared against the D1 peptide 
(Dlm) or the whole protein (M3AS) (Allan and Kreis, 1986; 
Pepperkok et al.,  1993). We were unable to use peptides to 
neutralize antibody inhibition due to the sensitivity of  our as- 
say to the high concentrations required for this purpose (Pep- 
perkok et al.,  1993). Antibody inhibition could be neutral- 
ized in all cases by preincubation with recombinant/S-COP 
(data not shown); however, neither recombinant/~-COP nor 
partially purified coatomer (Waters et al.,  1992) could re- 
verse the inhibition. In contrast, rat liver cytosol was found 
to efficiently reverse inhibition by Dlm (Fig. 1, h-i) and other 
antibodies tested (data not shown). No inhibition of trans- 
port was observed in the presence of antibodies w~ich de- 
tect proteins unrelated to vesicular traffickingl as has been 
demonstrated previously (Plutner et al.,  1991). 
To insure that inhibition was not simply the result of  aggre- 
gation  of/S-COP on the  membranes,  F,b fragments were 
prepared from M3AS. As shown in Fig.  1 B, F,b fragments 
inhibited transport in a dose-dependent fashion with close to 
90%  efficiency. F,b fragments were found to consistently 
yield a more complete inhibition than intact antibodies and 
did not require preincubation, suggesting rapid binding to 
the biologically active forms of/S-COP (data not shown). 
Given the suggestion that/S-COP is likely to be involved 
in vesicle formation (Waters et al., 1991b), we examined the 
with an additional portion (50 #g) of rat liver cytosol to reverse in- 
hibition. (B) Permeabilized cells, cytosol, and ATP were pretreated 
with increasing concentration of M3A5 F,b fragments for 60 inin 
on ice before incubation in vitro for 75 rain at 32°C. (C) Permeabi- 
lized cells were incubated for increasing time at 32°C in the pres- 
ence of cytosol and ATP before transfer to ice (open circles). Cells 
were subsequently incubated in the presence of the Dlm (4 pg) 
(closed circles), M3A5 F~b fragments (4 #g) (closed squares), or 
in the absence of  added antibody (control, open squares)  for 60 rain 
on ice. Cells were reincubated at 32°C for a total time of 75 rain 
(closed symbols). In these' experiments, the extent of transport was 
measured by determining the fraction of VSV-G processed to the 
endo  H  sensitive  form  (biochemical  assay) as  described  in 
Materials and Methods. 
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ER. NRK cells were permeabilized and preincubated in a complete 
cocktail containing cytosol and ATP in the presence (B) or absence 
(,4) of 5/tg M3A5 F~b fragments for 60 min on ice before incuba- 
tion in vitro at 32°C for 45 min. The distribution of VSV-G was 
determined using indirect immunofluorescence as described previ- 
ously (Plumer et al.,  1992). 
Figure 2. Incubation in vitro in the presence of a/5-COP specific 
monoclonal antibody (Dim) prevents export of VSV-G from the 
ER. NRK cells were permeabilized and preincubated in a complete 
cocktail containing cytosol and ATP for 75 rain on ice in the ab- 
sence (A and B) or the presence of 4 #g of a monoclonal antibody 
(Dim) specific for/3-COP (C) before incubation in vitroon ice (A) 
or at 32°C (B and C) for 45 rain as described previously (Plutner 
et al., 1992). The distribution of  VSV-G  at the end of  the incubation 
was determined using indirect immunofluorescence as described 
previously (Plutner et ai.,  1992). 
temporal  sensitivity  of  VSV-G  transport  to  the  /3-COP 
specific Dlm antibody and to M3A5 F~b fragments by add- 
ing these reagents after increasing time of incubation of cells 
in vitro. Both reagents inhibited transport at early, but not 
late times of addition (Fig. 1 C). After only 5-15 rain of in- 
cubation in vitro in the absence of antibody, time points in 
which <5 % of the total VSV-G was processed to Golgi as- 
sociated forms (Fig.  1 C, open circles), the majority (>80- 
90%) of  VSV-G transport was found to be insensitive to Dlm 
(Fig.  1 C,  closed circles) and M3A5 Fib fragments (Fig.  1 
C, closed squares).  These results support the interpretation 
that/3-COP may be required at an early step in vesicle bud- 
ding from the ER. 
A  morphological approach was also used to analyze the 
effects of/3-COP specific antibodies on the transport of VSV 
from the ER to the Golgi in digitonin permeabilized cells 
grown on coverslips (Plutner et al.,  1992). In this assay, we 
use indirect immunofluorescence and a temperature-sensi- 
tive form of VSV-G (strain tsO45)  (Phitner et al.,  1992). 
tsO45 VSV-G is found exclusively in the ER when cells are 
maintained  at the  restrictive temperature (39.5°C)  before 
permeabilization (Fig. 2 A). Upon incubation of permeabi- 
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tected  on  pre-Golgi  inter- 
mediates. Permeabilizod cells 
were  incubated  in  the  pres- 
ence of cytosol and ATP for 
15  min as described  in Ma- 
terials  and  Methods.  The 
distribution of/5-COP (using 
Dim)  (A) and p58  (B) were 
determined as described pre- 
viously (Plutner et ai., 1992). 
The arrows indicate examples 
of punctate  structures  which 
contain both p58 and/~-COP. 
These  pre-Golgi  intermedi- 
ates containing VSV-O do not 
colocalize with the cislmedial 
Golgi enzyme c~-1,2  mannosi- 
dase II (data not shown). 
lized cells at the permissive temperature (32°C) in the pres- 
ence of cytosol and ATE tsO45 VSV-G is transported via 
punctate, pre-Golgi intermediates, which consist of clusters 
of carrier vesicles and small tubules (Pind et al.,  1993), to 
the Golgi stack (Fig. 2 B) (Plutner et al., 1992; Schwaninger 
et al., 1992). Incubation in the presence of the Dim antibody 
completely inhibited export from the ER.  VSV-G was re- 
tained in the extensive reticulum observed before incubation 
in vitro (Fig. 2, compare A-C). Export from the ER was also 
strongly inhibited by the addition of M3A5  Fab fragments 
(Fig. 3 B). No discernible effect of either intact antibody or 
F,b fragments on Golgi structure could be detected based 
on the distribution of the oL-1,2-mannosidase II, a cis/medial 
Golgi  marker  protein  (data  not  shown).  These  results 
confirm the early effect of/3-COP specific antibodies mea- 
sured biochemically (Fig. 1 C), and further indicate that in- 
hibition is not a consequence of blocking either the function 
of the cis-Golgi compartment as an acceptor, or inhibiting 
indirectly the processing VSV-G to various endo D sensitive 
and endo H resistant forms. 
#-COP Colocalizes with p58 in 
Pre-Golgi Intermediates 
To determine whether the punctate, pre-Golgi transport in- 
termediates  observed  using  indirect  immunofluorescence 
contained/3-COP (Fig. 2 B), we examined the morphologi- 
cal distribution of/3-COP after 15 min of incubation in vitro 
and compared its distribution to that of the pre-Golgi inter- 
mediate marker protein p58 (Saraste and Svensson,  1991). 
As shown in Fig. 4 A, B-COP was detected in the Golgi re- 
gion and strongly colocalized with p58 containing punctate 
structures (Fig. 4 B). Using confocal microscopy, the extent 
of colocalization was determined to be nearly 75 % (data not 
shown).  We have previously demonstrated that these p58 
containing intermediates are enriched in both VSV-G and 
rablB after 15 min incubation in vitro (Plutner et al.,  1992; 
Schwaninger et al., 1992). The combined morphological and 
biochemical analyses are consistent with the interpretation 
that vesicles mediating ER to Golgi transport acquire both 
B-COP and rablB at an early step, presumably during vesicle 
budding. 
Cytosolic Forms of  [3-COP and RablB Are Required for 
Export  from the ER 
Efficient inhibition of transport by both the/3-COP specific 
M3A5 and rablB specific m4D3c antibodies requires prein- 
cubation of cells for 45-60 min on ice, presumably to allow 
for the  formation of immune  complexes  (Plutner  et  al., 
1991). We previously reported (Plutner et al., 1991) that in- 
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Figure 5. Rat liver cytosol reverses inhibition of transport by rablB 
specific antibodies.  Semi-intact cells were either not treated  (a-c) 
or pretreated  (d-0 with m4D3c on ice as described in Materials  and 
Methods.  Subsequently,  cells  were incubated  in the presence of 
cytosol which was either not treated  (a-e), mock-treated (f-g), or 
incubated  with m4D3c overnight on ice as described in Materials 
and Methods.  Transport was determined using both the biochemi- 
cal (endo D sensitivity) (open bars) and morphological (solid bars) 
assays as described in Materials and Methods.  Transport conditions 
were as follows: (a) incubation in vitro at 32°C in the absence of 
cytosol; (b and c) incubation in vitro at 32°C in the presence of un- 
treated cytosol; (d and e) ceils were pretreated  with m4D3c for 75 
min on ice, washed to remove excess antibody, and incubated  in the 
presence of untreated cytosol; (fand g) permeabilized cells were 
pretreated  with m4D3c for 75 min on ice, washed,  and incubated 
with cytosol which had been incubated  overnight on ice in the ab- 
sence of  antibody; and (h and i) permeabilized  cells were pretreated 
with m4D3c for 75 min on ice, washed, and incubated with cytosol 
which had been pretreated  with m4D3c overnight  on ice. 
hibition by m4D3c could not be reversed by the addition of 
cytosol  prepared  from  CHO  cells,  but  was  reversible  by 
components released from CHO membranes, suggesting that 
a membrane-bound form of rablB was required. In contrast, 
we have now found that rat liver cytosol efficiently reverses 
inhibition as measured biochemically by the acquisition of 
endo D  resistance (Fig.  5, lane d) or using indirect immu- 
nofluorescence as a semiquantitative method to monitor the 
maturation of VSV-G to punctate,  pre-Golgi intermediates 
and to the Golgi stack (Fig. 5, lane e). Consistent with these 
results,  rat liver cytosol was found to contain a substantial 
pool of a soluble form of rablB (see below) which could not 
be detected in CHO cytosol (Plutner et al.,  1991). Since fac- 
tors  involved in vesicle budding  must extensively  recycle, 
their distribution between membrane and/or soluble forms 
is likely to reflect the steady state concentration of various 
precursor pools in different tissues.  As rat liver cytosol can 
be used to efficiently reverse inhibition by both fl-COP and 
rablB specific antibodies, it provides us with a soluble source 
to explore  the  functional  relationships  between  these  two 
proteins. 
To examine the relationship between the function of rablB 
and/3-COP in the transport of VSV-G to either pre-Golgi in- 
termediates (morphological assay) or to the cis-Golgi com- 
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Figure 6. Vesicle budding and transport to the cis-Golgi show simi- 
lar  requirements  for  rablB  and  /3-Cop. Rat  liver  cytosol  was 
pretreated  overnight  on ice with increasing  amounts of the rablB 
specific (m4D3c) (closed circles) or/3-COP specific (M3A5) (open 
triangles) monoclonal antibodies  as described  in  Materials  and 
Methods.  Supernatants  were subsequently  assayed either for their 
ability  to  support  export  from  the  ER  using  indirect  im- 
munofluorescence  (morphological  assay  [.4]) or  processing  of 
VSV-G to the endo D sensitive form (biochemical  assay [B]) as de- 
scribed in Materials  and Methods.  A monoclonal antibody specific 
for rab2 (m2Clla) which does not inhibit transport is shown with 
the open squares. 
partment (biochemical assay), we established conditions to 
independently  inactivate  both  components  by  incubating 
cytosol overnight on ice with specific antibody. In the case 
of  the  rabl  specific  m4Dc3  antibody,  when  pretreated 
cytosol was centrifuged to remove possible  immune com- 
plexes, the resulting supernatant failed to support processing 
of VSV-G to the cis-Golgi endo D sensitive form (Fig. 5, lane 
h) and the transport of VSV-G from the ER to punctate, pre- 
Golgi  intermediates  when  quantitated  using  indirect  im- 
munofluorescence (Fig. 5, lane i). Cytosol can be inactivated 
by pretreatment  with the rablB  specific antibodies m5C6b 
and p68, but not with other monoclonal antibodies including 
one specific for rab2 (m2C1 la) (Fig. 6), an IgM specific for 
NSF (SEC18) (Beckers et al.,  1989),  nor monoclonal anti- 
bodies to antigens unrelated to vesicular transport (data not 
shown). When the concentration of m4D3c required to inac- 
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can be coprecipitated from rat 
liver  cytosol.  Immune  com- 
plexes formed by incubation 
of rat liver cytosol in the pres- 
ence  of  m4D3c  (c~-rablB) 
(a-c)  or  M3A5 (ct-B-COP) 
(e-f) were separated by SDS- 
PAGE, transferred to nitrocel- 
lulose and the distribution of 
rablB (a and e), B-COP (b and 
f) and a cross-reactive species 
to yeast SEC23 (sec23m) (c 
and g) detected using Western 
blotting as described  in Ma- 
terials  and  Methods.  The 
separations  were  performed 
using either  10% SDS-PAGE 
for  B-COP and  sec23m,  or 
15%  SDS-PAGE for  rablB. 
The portion of  the gel contain- 
ing  the  indicated  protein 
(large arrowheads) is shown. 
RablB  and  B-COP migrated 
with  the  expected molecular 
weights based on comparison to the recombinant protein. The small arrows indicate the position of the heavy or light chains present in 
the immune precipitate which are detected by the secondary HRP-conjugated reagent. 
tivate cytosol was determined,  both budding from the ER 
and delivery to the cis-Golgi  compartment were inhibited 
with similar efliciencies (ECs0 ,x,l.5  ng antibody/#g cyto- 
sol) (Fig. 6, compare closed circles in A [morphological as- 
say] to closed circles in B [biochemical assay]) with maximal 
inhibition in the presence of ~  3-4 ng antibody/#g cytosol. 
Under these saturating  conditions,  ~20-30%  of the total 
rablB could be pelleted in the form of immune complexes 
based on Western blotting (data not shown). 
A  similar result was obtained using the B-COP specific 
M3A5 antibody. After pelleting to remove the precipitate, we 
found that the supernate failed to support either the transport 
of VSV-G from the ER to pre-Golgi intermediates (Fig. 6 A, 
open triangles) or processing of VSV-G to the endo D sensi- 
tive form (Fig. 6 B, open triangles).  In this case, the EC~0 
for inhibition of transport was "~2-3 ng antibody/#g cytosol 
for  both  assays  with  maximal  inhibition  at  ~6  ng  anti- 
body/#g cytosol. Under saturating conditions only 10-20% 
of the total rablB could be pelleted from cytosol based on 
Western blotting (data not shown). For both antibodies, the 
concentration of M3A5 or m4D3c required to inhibit trans- 
port when preincubated with cytosol overnight was *5-10- 
fold lower than the amount required when added directly to 
an assay (,~50 ng//zg cytosol), presumably reflecting the ki- 
netics of antibody-complex formation. 
The strong correlation between the requirement for B-COP 
and  rablB  for vesicle budding  (morphological assay)  and 
transport to the cis-Golgi (biochemical assay) suggests that 
the punctate structures observed using indirect immunofluo- 
rescence are  bona  fide  carrier  vesicles mediating  ER  to 
Golgi transport. 
A  High Molecular Weight Protein Complex 
Stimulates Export of VSV-G  from the ER but Not 
Transport to the Golgi 
The observation that '~20-30% of the rablB forms a pellet- 
able immune complex in the presence of  m4D3c is consistent 
with our previous observation that rablB containing immune 
complexes can  be  readily  detected using  indirect  immu- 
nofluorescence (Schwaninger et al.,  1992). Since m4D3c is 
a monoclonal antibody, these complexes must contain multi- 
ple copies of rablB and possibly other transport components 
related  to  rabl  function.  To  explore  this  possibility,  the 
precipitate formed by overnight incubation on ice was ana- 
lyzed using Western blotting. We detected not only rablB, 
but both B-COP and a cross-reacting species to yeast Sec23p 
(sec23m), a SAR1 specific GAP involved in export from the 
ER in yeast (Yoshihisa et al., 1993) (Fig. 7, a-c). In contrast, 
we did not detect NSF or rab2 (data not shown). Conversely, 
when the B-COP specific M3A5 was added to cytosol and 
the  pelletable  immune  complex examined using  Western 
blotting, we found B-COP, rablB and sec23m (Fig. 7, d-f). 
Neither rablB, ~-COP, nor sec23m were detected in the ab- 
sence of specific antibody (data not shown). 
To ascertain the size of these protein complexes possibly 
involved in ER to Golgi transport, cytosol, prepared by cen- 
trifugation at 150,000 g for 1.5 h to insure removal of poten- 
tial vesicular contaminants, was gel-filtered over a Superose 
6 FPLC column. Colunm fractions were simultaneously as- 
sayed for (a) export to pre-Golgi intermediates (morphologi- 
cal assay), (b) transport to the cis-Golgi compartment (bio- 
chemical assay), and (c) the distribution of rablB, ~COP, 
ARF1, and sec23m. 
Two peaks of activity supporting vesicle budding from the 
ER were detected based on the morphological assay.  These 
together accounted for 50-70% of the total activity loaded 
on the column (Fig. 8 A, open circles). One peak, containing 
<20-30% of the total activity stimulating export of VSV-G 
from the ER to pre-Golgi intermediates was found in the in- 
cluded fractions (Fig.  8 A, open  circles  [fractions 8-13]). 
These fractions are likely to contain coatomer (Waters et al., 
1992) as indicated by the distribution of B-COP (Fig. 8 B). 
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the ER, but not transport to the cis-Golgi compartment. (A) Rat 
liver cytosol was gel filtered  on a  Superose 6  TM  column as de- 
scribed in Materials  and Methods. Fractions were assayed for both 
biochemical (endo D sensitivity)  (closed circles) and morphologi- 
cal (open circles) transport as described in Materials  and Methods. 
(B) The distribution  of/3-COP, ARF, rablB, and sec23m was deter- 
mined by Western blotting as described in Materials  and Methods. 
Only the portion of  the gel containing the relevant protein is shown. 
The asterisk (*) indicates that the amount of material  loaded on the 
gel in these loads was increased 10-fold over that used in all other 
lanes  to enhance the signal  for rablB. 
In addition to vesicle budding, these fractions also supported 
transport of VSV-G to the Golgi based on both indirect im- 
munofluorescence (data  not shown)  and the processing of 
VSV-G to the endo D  sensitive form (Fig.  8 A, closed cir- 
cles). In contrast, the majority (60-80%) of the export activ- 
ity  detected  using  indirect  immunofluorescence  was  rou- 
tinely found in the voided fractions (Fig.  8 A, open circles 
[fractions 5-8]), and therefore contains components or com- 
plexes  with  putative  molecular  weights  >1,000  kD.  The 
specific budding activity in the void pool was generally 7-10- 
fold higher than that found in the crude cytosol. This pool 
lacked  detectable  lipid  (data  not  shown),  eliminating  the 
trivial possibility that the void fraction contained transport 
vesicles which could contribute coat precursors.  Although 
this pool supported efficient transport of VSV-G to pre-Golgi 
intermediates  (Fig. 9 A, arrows), we could not detect trans- 
port to the Golgi stack using indirect immunofluorescence 
(data not shown), nor was VSV-G processed to the endo D 
sensitive form (Fig.  8 A, closed circles). 
Consistent with the observation that vesicle budding from 
the  ER  required  /3-COP  and  rablB,  a  significant  pool 
(,o10-20% based on quantitative immunoblotting) could be 
Figure 9. The vesicle budding activity of Superose 6 void fractions 
requires/3-COP.  Permeabilized  cells and 40 #1 of the pooled void 
fractions were preincubated for 60 min on ice in the absence (,4) 
or presence (B and C) of Dim. In C, the assay was supplemented 
with an additional 40 ~tl of the void pool before incubation at 32°C. 
Subsequently,  cells were incubated for 45 min at 32°C. Export of 
VSV-G from the ER to pre-Golgi intermediates  was detected using 
indirect immnnoflnorescence as described in Materials  and Meth- 
ods. The punctate structures  in A and C colocalize with the pre- 
Golgi intermediate  marker protein p58 (see Fig. 4). 
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Figure 10. The biologically active protein complex found in the void 
fractions contains both rablB and/$-COP and sentiments as a ,o18- 
19S complex using sucrose density centrifugation.  (A) The void 
pool was incubated in the presence of no antibody (a-d), M3A5 
(/~-COP specific) (e-g) or m5C6b (rablB specific) (h-j) antibodies 
as described in Materials and Methods. Proteins bound to protein 
A-Sepharose  beads  were  eluted,  separated  using  SDS-PAGE, 
transferred to nitrocellulose for Western blotting, and quantitated 
using densitometry. The values reported are the percent of total 
rablB or/3-COP present in the void pool bound to beads in the pres- 
ence or absence of antibody (P) or, where indicated, the amount 
of protein remaining in the supernatant (S). (B) The void pool was 
prepared and analyzed using sucrose density centrifugation as de- 
scribed in Materials and Methods (Duden et al., 1991b). Samples 
from each sucrose gradient fraction were separated using SDS- 
PAGE and transferred to nitrocellulose for Western blotting. The 
distributions of rablB and/$-COP are illustrated.  The standards 
used to calibrate the gradient were catalase (4.3S),  BSA (11.1S), 
and bovine thyroglobulin (16.5S) as used previously for determina- 
tion of the coatomer S value (Duden et al.,  1991b). 
detected in the void fractions. RablB could also be detected 
in  two  pools,  one  corresponding  to  the  high  molecular 
weight void fractions ('o10-20% of total based on quantita- 
tive immunoblotting [data not shown]), and the remainder in 
a second pool found in the included fractions (Fig. 8 B). Its 
distribution in the included fraction was coincident with the 
peak of activity supporting complete transport to the cis- 
Golgi compartment and overlapped in part with the broad 
distribution of/S-COP (Fig. 8 A). These results are consistent 
with the observation that "o20% of the total pools of rablB 
or/S-COP found in crude cytosol form a peUetable precipi- 
tate in the presence of specific antibody. In addition, sec23m 
was detected in the void pool (,o10-15 % of total based on 
Western blotting). In contrast, all of the ARF (>98 %) (Fig. 
8 B) and NSF (data not shown) were found in the included 
fractions. 
RablB and #-COP Found in the Void Fractions Form a 
Functional Complex 
We have demonstrated up to this point that the void fractions 
contain high molecular weight forms of rablB and/S-COP, 
contain a significant fraction of the budding activity eluting 
from the Superose 6 column and, in addition, have a 7-10- 
fold increase in specific activity over that found in the crude 
cytosol. We were curious as to whether the void fractions 
contained two distinct complexes-one containing multiple 
copies of rablB and a second containing/S-COP, or whether 
they formed a common complex active in vesicle budding. 
To determine whether there was a physical association be- 
tween rablB and/S-COP, the void fraction was treated with 
rablB and B-COP specific antibodies in the presence of pro- 
tein A-Sepharose beads.  Proteins recovered on the beads 
were analyzed using Western blotting. As shown in Fig. 10, 
protein A beads incubated in the absence of either m4D3c 
or M3A5 antibodies failed to bind detectable levels of/S-COP 
or rablB (Fig. 10 A; a and c). In contrast, all the rablB (99 %) 
and ,'o40% of  the total/S-COP pool found in the void fraction 
was associated with the beads in the presence of the anti- 
rablB antibody (Fig. 10 A; h and i). Addition of recombinant 
rablB to the mixture before addition of specific antibody 
blocked coprecipitation of/S-COP (data not shown).  Con- 
versely, the/S-COP specific M3A5 antibody immunoprecipi- 
tated >99 % of the total/S-COP with 50 % of the total rablB 
in the void (Fig. 10 A; e and g). The recoveries observed in 
the protein A-Sepharose pellets reflect the partial dissocia- 
tion of complexes during washing  steps,  as no detectable 
/S-COP or rablB remained in the supernatant of antibody/ 
protein A-treated cytosol (Fig.  10 A; fandj).  In contrast, 
we have observed that neither antibody will coprecipitate 
rablB  or  /S-COP  from  the  included  fractions  (data  not 
shown). 
Consistent with the ability of rablB and/S-COP to form a 
complex, analysis of  the void pool using sucrose density gra- 
dient  centrifugation  demonstrated  that  both  rablB  and 
/S-COP cosedimented as an "o18-19S particle, similar in den- 
sity to the distribution of a SEC4 containing particle (19.5S) 
(Bowser et al., 1992). RablB could also be detected in earlier 
gradient fractions, presumably reflecting partial dissociation 
from the complex during the centrifugation (Fig.  10 B). 
To demonstrate that the high molecular weight forms of 
/S-COP and rablB were required for vesicle budding, the void 
fraction was preincubated in the presence of/S-COP specific 
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Figure 11. The high molecular Ix~ol  promotes the formation of  func- 
tional transport  vesicles. Permeabilized cells were incubated in 
vitro for 90 min at 32°C in the presence of untreated cytosol (lane 
a) or 40 #1 of the void pool (lanes b, e, and f) in the absence (lane 
b) or presence of cytosol pretreated with rablB specific m4D3c 
(lane e), or/3-COP specific M3A5 (lane  f) antibodies by overnight 
incubation on ice as described  in Materials and Methods. The 
transport activity of m4D3c- or M3A5-treated cytosols when in- 
cubated alone is shown in lanes c and d, respectively. The amount 
of VSV-G processed to the endo H resistant form was quantitated 
as described in Materials and Methods. 
or rablB specific antibodies. As expected, both M3A5 (Figs. 
6  A  and 9  B) and m4D3c (Fig.  6 A)  inhibited export of 
VSV-G  from the  ER to punctate pre-Golgi intermediates 
based on indirect immunofluorescence. When the M3A5- 
treated sample (Fig. 9 B) was supplemented with an addi- 
tional portion of the void pool, transport of VSV-G to punc- 
tate,  pre-Golgi intermediates was  restored (Fig.  9  C).  In 
contrast,  supplementation of the  depleted void pool with 
purified coatomer (Waters et al., 1992) failed to reconstitute 
export. Moreover, purified coatomer when added directly to 
a transport reaction containing the biologically active pool 
of/3-COP found in the void pool, neither stimulated nor in- 
hibited vesicle budding (data not shown). 
Pre-Golgi Intermediates Formed in the Presence 
of the RablB/[3-COP Containing Complex Transport 
VSV-G to the Golgi When Supplemented with 
Late-acting Factors 
To provide a  final line of evidence that the fl-COP/rablB 
complex found in the void fraction generates bona fide car- 
rier vesicles, rat liver cytosol was inactivated by pretreat- 
ment with either m4D3c or M3A5 antibodies in the presence 
of protein A-Sepharose (Fig. 11, c and d). Subsequently, the 
depleted cytosols were incubated in the absence (Fig.  11, c 
and d) or presence (Fig. 10, e and  f) of  the void pool. In both 
cases,  transport was restored to a  level which was nearly 
50% of the control incubation containing an identical amount 
of non-depleted cytosol (Fig. 11 a). These results are consis- 
tent with our previous observation that the void pool contains 
a significant fraction of the total vesicle budding activity and 
that the included fraction, in addition, contains critical fac- 
tors to support targeting and fusion (Fig.  8 A). 
Discussion 
E-COP Is Required for ER to Golgi Transport 
The major focus of this paper was to establish a biological 
role for/3-COP in ER to Golgi transport in order to begin 
to analyze its molecular interactions with other known trans- 
port components. We provided two lines of evidence based 
on both biochemical and morphological criteria that/3-COP 
participates at an early step involved in vesicle budding from 
the ER. First, four antibodies raised against synthetic pep- 
tides derived from different regions of/3-COP (Pepperkok et 
al.,  1993)  as well as F,b fragments generated from M3A5 
inhibited export of VSV-G from the ER. Second, the active 
pools of/3-COP found in rat liver cytosol could be depleted 
or inactivated by overnight incubation on ice in the presence 
of specific antibodies. In both cases, transport activity could 
be recovered by addition of fractions containing the active 
forms of/3-COP. 
A number of observations are consistent with our observa- 
tion that/3-COP is involved in vesicular traffic. First, ~COP 
is a component of non-clathrin coats found on vesicles bud- 
ding  from  the  Golgi  compartments  (Orci  et  al.,  1991; 
Serafini et al., 1991b; Waters et al., 1991b) and accumulates 
on vesicles when Golgi stacks are incubated in the presence 
of GTP3"S (Melancon et al., 1989). Second, the yeast homo- 
logue to 3,-COP (Sec21p) is essential for ER to Golgi trans- 
port in yeast (Hosobuchi et al.,  1992; Novick et al.,  1980). 
Third, a number of reports have now demonstrated the local- 
ization of/3-COP to the transitional region of the ER, pre- 
Golgi intermediates and to the cis face of the Golgi stack in 
vivo (Duden et al.,  1991b;  Oprins et al.,  1993; Hendricks 
et al., 1993; Pepperkok et al., 1993). Finally, cells microin- 
jected with/3-COP specific antibodies inhibit ER to Golgi 
transport in vivo, resulting in the accumulation of VSV-G in 
pre-Golgi intermediates  (Pepperkok et  al.,  1993).  These 
results differ significantly from our results in which/3-COP 
antibodies were found to inhibit vesicle formation and pre- 
vent transport  of VSV-G  to  the  pre-Golgi intermediates. 
Given the technical limitations of microinjection, a likely ex- 
planation for the observed differences is the inability of anti- 
bodies to completely inhibit/3-COP function in vivo, allow- 
ing  for the  partial  maturation  of VSV-G  to  intermediate 
carriers,  but preventing further transport  due to  either a 
more pronounced effect on vesicle uncoating or its potential 
effect on inhibiting the function of the acceptor cis-Golgi 
compartment in vivo. The combined results demonstrate the 
use of  an in vitro approach to quantitatively deplete or inacti- 
vate the functional/3-COP pool before incubation to identify 
its initial site of action. 
Our results provide the first direct biochemical demonstra- 
tion for the biological functionality of/3-COP in vesicle bud- 
ding, in this case, export from the ER. Importantly, they es- 
tablish a role for/3-COP in initiating the anterograde flow 
of itinerant  protein  through  early  steps  of the  secretory 
pathway. 
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A major problem in understanding/S-COP function has been 
to identify biologically active forms since this protein can 
distribute  quite  heterogeneously  during  fractionation  of 
crude rat liver cytosol.  The /~-COP containing coatomer 
complex has been postulated to fulfill this function (Waters 
et al., 1991b; Orci et al., 1993),  although existing evidence 
is still indirect concerning the formation of vesicles compe- 
tent for targeting and fusion. Based on an assay that mea- 
sured the formation of  ER to Golgi carrier vesicles, we found 
that/S-COP could be fractionated from rat liver cytosol into 
at least two functional pools using gel filtration. One pool 
was  found  in  the  included  fractions  and  contained  the 
majority (>80%) of the/S-COP found in cytosol. This frac- 
tion had markedly less total activity in stimulating export of 
VSV-G from the ER to pre-Golgi intermediates based on in- 
direct immunofluorescence. This pool also contained other 
factors essential for the delivery of VSV-G to the cis-Golgi 
compartment.  Given that coatomer  is  typically prepared 
from this fraction (Waters  et al.,  1991), we were surprised 
to find that even partially purified coatomer failed to recon- 
stitute vesicle budding under a number of different condi- 
tions. Our inability to reconstitute export with coatomer sug- 
gests that purification of the complex from cytosol results in 
the loss of essential components required for coat assembly 
(see below). 
A second high molecular weight pool contained only 10- 
20% of the total/S-COP. However,  it contained 60-80%  of 
the export activity with a 5-10-fold higher specific budding 
activity than found in cytosol. This pool promoted efficient 
export of VSV-G from the ER to punctate, p58 containing 
pre-Golgi vesicular carriers, but did not support subsequent 
transport to the Golgi stack, p58 has been shown in a number 
of cell lines, including the NRK cells used in our studies, to 
be a marker for pre-Golgi tubular-vesicular intermediates in 
vivo (Saraste and Svensson, 1991). Using immunoelectron 
microscopy, we have recently shown that the punctate, pre- 
Golgi intermediates containing VSV-G observed in vitro are 
similar in structure to those observed in vivo. They consist 
of a collection of small 40-80-nm vesicles and small tubular 
elements whose function is regulated by rabl (Schwaninger 
et al., 1992; W. E. Balch, unpublished observations). A role 
for/S-COP in the vesicle budding from the ER is consistent 
with the striking abundance of/S-COP in these vesicular car- 
riers at early time points as shown here in vitro and in vivo 
(Pepperkok et al., 1993). Since vesicular carriers formed by 
incubation in the presence of the high molecular weight frac- 
tion were efficiently transported to the Golgi after the addi- 
tion of late-acting factors found in the included fractions, it 
is clear that the void contains all of the essential ingredients 
to form functional vesicles. This important result now pro- 
vides us with a direct assay for late-acting components. 
We also detected in the void fraction a mammalian protein 
of,~70 kD which cross-reacted with an antibody that recog- 
nizes the yeast SEC23 gene product. A mammalian homo- 
logue to Sec23p has been previously localized to vesicular 
profiles in the ER/Golgi transitional region in pancreas (Orci 
et al.,  1991a).  Biochemical and genetic evidence suggests 
that Sec23p along with a limited number of other proteins 
is essential for vesicle budding from the ER (Hicke and 
Schekman, 1989; Kaiser and Schekman, 1990; Hicke et al., 
1992; d'Enfert et al., 1992; Barlowe et al., 1993; Yoshihisa 
et al., 1993).  Further experiments using antibodies specific 
for the mammalian homologue will be necessary to conform 
and extend the role of this protein in vesicle formation. It is 
important to point out that we did not detect NSE rab2, or 
ARF  in  the  void  fractions,  proteins  we  have previously 
demonstrated to  be  essential  for  ER  to  Golgi  transport 
(Beckers et al., 1989; Balch et al., 1992; Schwaninger et al., 
1992;  Tisdale et al.,  1992).  These results make it unlikely 
that  the  biologically  active  void pool  represents  a  non- 
specific association of cytosolic proteins. The lack of NSF 
is consistent with its postulated role in a late vesicle targeting 
or fusion step (for review see Rothman and Orci, 1992). Al- 
though ARF was apparently not required in a soluble form 
for vesicle budding from the ER in vitro, the semi-intact cells 
used in our assay contain a significant pool of bound ARF 
(Peter,  E,  and W.  E.  Balch,  unpublished results).  Given 
previous observations concerning the possible role of ARF 
in recruitment of/S-COP (Donaldson et al., 1992), this pool 
is likely to contribute significantly to vesicle budding. 
[3-COP and rablB Form a Functional Precoat Complex 
When  we  began  to  analyze the functional basis  for  the 
/S-COP dependence of ER to Golgi transport, we unexpect- 
edly found a high correlation between transport activity, and 
the codistribution of/S-COP and rablB in the void fraction. 
A  major concern given current technical limitations was 
whether the high molecular fraction constitutes a functional 
precoat complex and not a non-specific mixture of cytosolic 
proteins. In addition to the observation that the void fraction 
contains only a  subset of transport components, there are 
several lines of evidence to suggest, but do not prove, that 
it represents a  precoat complex.  First,  rablB and/S-COP 
could be coprecipitated from these fractions with concomi- 
tant loss of transport activity. In neither case could the two 
proteins be coprecipitated from the included fractions, al- 
though  they  efficiently inactivated  the  transport  activity 
found in these fractions. These results attest to the functional 
importance of both low and high molecular forms of rablB 
and/S-COP,  and in the case of the high molecular weight 
form, is consistent with its ability to sediment as a  18-19S 
particle. Rabl is not the first member of the rab family to be 
detected in high molecular complexes. SEC4 can be readily 
detected in a  large protein complex which fractionates as 
19.5S particle (Bowser et al., 1992). This complex contains 
SEC8  and SEC15,  and possibly other components recog- 
nized to mediate vesicle traffic from the Golgi to the cell sur- 
face. Rab5 has also been reported to be found in a larger ag- 
gregate, but only when cells are depleted ofATP (Kurzchalia 
et al.,  1992).  These studies are unrelated both in principle 
and practice to our current studies since they do not address 
the question of functionality, involve chemical cross-linking, 
and the observed protein complexes form only under unusual 
incubation conditions. In our studies, we have used specific 
antibodies and direct biological assays to correlate the time- 
tional distribution of/S-COP and rabl  with other cellular 
components potentially involved in ER to Golgi traffic under 
normal incubation conditions. 
A second line of evidence which supports our interpreta- 
tion that the high molecular fraction represents a function- 
ally important precoat complex is the "o5-10-fold increase 
in specific budding activity found in the void pool over that 
observed  in the cytosol.  When combined with restricted 
ability of this complex to only support vesicle budding and 
the observation that only 10-20% of the total/S-COP resides 
Peter et al. E-COP and Rabl Function  in ER Export  i165 in this fraction, we consider it unlikely that the void pool 
represents  a heterogeneous collection of components found 
in the cytosol.  Our evidence suggests that these complexes 
contain multiple copies of rablB and/3-COP,  and that the 
function of each of these proteins is required for vesicle bud- 
ding given the ability of Fe fragments to inhibit transport. 
Consistent  with this  observation,  we have  found that  the 
complex  can  be  inactivated  by  separation  of rablB  from 
/~-COP using ion exchange chromatography (Peter,  E, and 
W. E.  Balch,  unpublished  results).  Further  biochemical 
characterization of the complex is now in progress. 
Functional Significance  of  a 
RablB/~-COP-containing Complex 
What  is  the  functional  significance  of the  association  of 
rablB  and/3-COP  in a  precoat particle?  One possible in- 
terpretation  is that these two proteins may be coordinately 
recruited during vesicle formation and that rablB plays an 
important, but at the present time, unknown role in this pro- 
cess.  This would be consistent with our observations that 
trans dominant mutants  in GTP-binding proteins of rabl in- 
hibit vesicle budding (Nuoffer, C., and W. E. Balch, manu- 
script submitted for publication). This is also consistent with 
the ability of F,b fragments to inhibit vesicle formation. Al- 
ternatively,  ~-COP or other components present in the com- 
plex are essential  for budding,  and rablB,  while recruited 
during vesicle formation, functions at a late step in transport. 
The latter interpretation  is consistent with the role of rabl 
GTP-hydrolysis in vesicle targeting or fusion in vivo (Tisdale 
et al.,  1992) and in vitro (Pind et al.,  1993), as well as the 
possible role of YPTI in ER to Golgi transport in yeast (for 
review see Pryer et al., 1992). Interestingly,  genetic studies 
have demonstrated that YPT1  and SEC21  (-/-COP) may in- 
teract through the action of SLY1 (Dascher et al., 1991; Os- 
sig et al.,  1991),  suggesting a role for YPTI in the function 
of/3-COP in yeast.  We do not find it surprising that rablB 
is associated with larger complexes, particularly those con- 
talning  components  involved  in  the  assembly  of vesicle 
coats.  Small GTP-binding proteins such as rablB serve as 
molecular switches which interface and control the inter- 
actions between upstream  and downstream  effectors.  The 
potential  ability  of rablB  to  participate  in  the  assembly/ 
disassembly of/3-COP containing non-clathrin coats is con- 
sistent with its role in ER to Golgi and intraGolgi transport 
(Schwaninger et al.,  1993;  Davidson and Balch,  1993). 
The role of/S-COP in membrane trafficking has been con- 
troversial  due to the observation that the drug brefeldin A 
(BFA) causes a global release of the protein from the Golgi 
stack and the collapse of these compartments into the ER. 
Such results have led to the suggestion that/3-COP primarily 
serves as a "capping" protein to prevent fusion between mem- 
branes (Klausner et al., 1992). In contrast, our results  pro- 
vide the first direct functional evidence for its role in vesicle 
formation from the ER. Given the likelihood that there is a 
strong link between organdie structure  and vesicular traf- 
ticking, it will be interesting to define the more global role 
of/3-COP and rabl in the maintenance of organelle structure/ 
function in the secretory pathway as the intricacies of their 
biochemical interactions become unraveled. 
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